According to new studies, the stimulant medication CONCERTA (OROS methylphenidate HCl extended-release tablets CII) has demonstrated a significant effect on children with attention deficit hyperactivity disorder (ADHD).

New studies have examined the effects of CONCERTA for the first time in a stimulated classroom setting. The results reportedly showed significant improvements in children with ADHD as measured by a validated, time-sensitive maths test, administered throughout the day.

At one-hour-post-dose intervals, the children who received CONCERTA attempted 38% more questions compared with the baseline, while those receiving a placebo showed no change from the baseline.